Renal Impairment
9 competing products in clinical development for Renal Impairment.
Pipeline by Phase
Phase 19
All Products (9)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| S-892216-PO | Shionogi | Phase 1 | Recruiting | 36 |
| YM178 | Astellas Pharma | Phase 1 | Completed | 29 |
| Bocidelpar | Astellas Pharma | Phase 1 | Completed | 29 |
| BPN14770 | Shionogi | Phase 1 | Completed | 29 |
| S-217622 | Shionogi | Phase 1 | Completed | 29 |
| Lorcaserin 10mg | Eisai | Phase 1 | Completed | 29 |
| Lemborexant | Eisai | Phase 1 | Completed | 29 |
| Lenvatinib | Eisai | Phase 1 | Completed | 29 |
| MBX 2109 + MBX 2109 + MBX 2109 + MBX 2109 | MBX Biosciences | Phase 1 | Completed | 23 |